Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment

Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment

Abstract In patients with atherosclerotic cardiovascular disease (ASCVD) under statin treatment, the influence of on-treatment level of high-density lipoprotein cholesterol (HDL-C) on cardiovascular (CV) events is controversial. Statin-treated patients were selected from the Taiwanese Secondary Prev...

Full description

Bibliographic Details
Main Authors:	Yi-Heng Li, Wei-Kung Tseng, Wei-Hsian Yin, Fang-Ju Lin, Yen-Wen Wu, I-Chang Hsieh, Tsung-Hsien Lin, Wayne Huey-Herng Sheu, Hung-I Yeh, Jaw-Wen Chen, Chau-Chung Wu, Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators
Format:	Article
Language:	English
Published:	Nature Portfolio 2020-12-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-020-78828-8

Similar Items

The waist-to-body mass index ratio as an anthropometric predictor for cardiovascular outcome in subjects with established atherosclerotic cardiovascular disease
by: Chin-Feng Hsuan, et al.
Published: (2022-01-01)

Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan.
by: Li-Ting Ho, et al.
Published: (2015-01-01)

Residual Risk Factors to Predict Major Adverse Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with and without Diabetes Mellitus
by: Fang-Ju Lin, et al.
Published: (2017-08-01)

Registry of Lipid Control and the Use of Lipid-lowering Drugs for Secondary Prevention of Cardiovascular Events in Patients with Established Atherosclerotic Disease in Taiwan: Rationality and Methods
by: Wei-Hsian Yin, et al.
Published: (2012-12-01)

Landscape of Statin as a Cornerstone in Atherosclerotic Cardiovascular Disease
by: Cheng Yang, et al.
Published: (2023-12-01)

Controlling the thickness of the atherosclerotic plaque by statin medication.
by: Dorota Formanowicz, et al.
Published: (2020-01-01)

Association of Major Adverse Cardiac Events and Beta-Blockers in Patients with and without Atherosclerotic Cardiovascular Disease: Long-Term Follow-Up Results of the T-SPARCLE and T-PPARCLE Registry in Taiwan
by: Patrick Yan-Tyng Liu, et al.
Published: (2023-03-01)

Underuse of statins in patients with atherosclerotic ischemic stroke in China.
by: Li, X, et al.
Published: (2012)

Metabolic changes with the occurrence of atherosclerotic plaques and the effects of statins
by: Lingmin Zhao, et al.
Published: (2023-12-01)

The association of atherosclerotic cardiovascular disease and statin use with inflammation and treatment outcomes in tuberculosis
by: Vignesh Chidambaram, et al.
Published: (2021-07-01)

Toward better diabetes care: Exploration and implementation
by: Wayne Huey‐Herng Sheu
Published: (2023-05-01)

Statins did not reduce the mortality risk in patients with bullous pemphigoid: A population-based cohort study
by: Chen-Yi Wu, et al.
Published: (2021-01-01)

Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks
by: Yu-Cheng Kao, et al.
Published: (2021-03-01)

The Risk of Atherosclerotic Cardiovascular Disease among Hyperlipidaemia Patients and Appropriateness of Statin Therapy
by: Maharani F. Iskandar, et al.
Published: (2018-04-01)

Statin Use for Atherosclerotic Cardiovascular Disease Prevention Among Sexual Minority Adults
by: Yi Guo, et al.
Published: (2020-12-01)

On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study
by: Li-Ting Ho, et al.
Published: (2018-09-01)

Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70–100 mg/dL in Taiwan
by: Fang-Ju Lin, et al.
Published: (2020-05-01)

Statins: a repurposed drug to fight cancer
by: Wen Jiang, et al.
Published: (2021-07-01)

[Current statin use for patients with atherosclerotic cardiovascular disease in 39 large Chinese hospitals].
by: Zhang, D, et al.
Published: (2011)

Patterns and gaps in guideline-directed statin use for atherosclerotic cardiovascular disease by race and ethnicity
by: Ashish Sarraju, et al.
Published: (2024-03-01)

Beyond Statins: Novel Lipid-Lowering Agents for Reducing Risk of Atherosclerotic Cardiovascular Disease
by: Teimur Kayani, et al.
Published: (2024-03-01)

Anti-atherosclerotic vaccination against Porphyromonas gingivalis as a potential comparator of statin in mice
by: Hyun-Su Ha, et al.
Published: (2021-04-01)

Intracranial Atherosclerotic Plaque Morphologic Pattern and Enhancement Change With High‐Intensity Statin Therapy
by: Sebastian Sanchez, et al.
Published: (2023-11-01)

Association between statin therapy and mortality in patients on dialysis after atherosclerotic cardiovascular diseases
by: Myunhee Lee, et al.
Published: (2023-07-01)

Use of Facebook by Academic Medical Centers in Taiwan During the COVID-19 Pandemic: Observational Study
by: Chu, Wei-Min, et al.
Published: (2020-11-01)

Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe
by: Yinchu Cheng, et al.
Published: (2022-10-01)

Impact of type D personality on clinical outcomes in Asian patients with stable coronary artery disease
by: Hsin-Bang Leu, et al.
Published: (2019-03-01)

[A cross-sectional study on the use of statin among patients with atherosclerotic ischemic stroke in China.]
by: Jiang, L, et al.
Published: (2010)

Saturated fat intake, statin therapy and atherosclerotic vascular disease: A prospective cohort study
by: L. Blekkenhorst, et al.
Published: (2014-12-01)

Updates for hyperglycemia in pregnancy: The ongoing journey for maternal–neonatal health
by: Hung‐Yuan Li, et al.
Published: (2022-10-01)

Effect of PCSK9 inhibition in combination with statin therapy on intracranial atherosclerotic stenosis: A high-resolution MRI study
by: Lingshan Wu, et al.
Published: (2023-03-01)

Hyperlipidemia, statin use and dengue severity
by: Chia, Po Ying, et al.
Published: (2018)

Gender Difference in Statin Intervention on Blood Lipid Control among Patients with Coronary Heart Disease
by: Chun-Yen Chen, et al.
Published: (2013-06-01)

Intensive statin versus low-dose statin + ezetimibe treatment for fibrous cap thickness of coronary vulnerable plaques
by: Pei-Na Meng, et al.
Published: (2020-10-01)

Cholesterol-lowering statin therapy to prevent atherosclerotic cardiovascular disease - Is the new guideline based on best evidence?
by: Canoy, D
Published: (2014)

Cholesterol-lowering statin therapy to prevent atherosclerotic cardiovascular disease - is the new guideline based on best evidence?
by: Canoy, D
Published: (2014)

Management of High-Risk Atherosclerotic Patients by Statins May Be Supported by Logistic Model of Intima-Media Thickening
by: Dorota Formanowicz, et al.
Published: (2021-06-01)

A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
by: Yi-Heng Li, et al.
Published: (2020-03-01)

Fenofibrate attenuates doxorubicin-induced cardiac dysfunction in mice via activating the eNOS/EPC pathway
by: Wen-Pin Huang, et al.
Published: (2021-01-01)

The association between statins and subsequent risk of bullous pemphigoid: A population-based cohort study
by: Tsung-Hsien Chang, MD, et al.
Published: (2021-06-01)